|
:''This article is primarily about Genetics Institute prior to its 1996 acquisition by Wyeth. For the current company, see Wyeth.'' Genetics Institute, Inc. was a biotechnology research and development company founded by Thomas Maniatis and Mark Ptashne, two Harvard molecular biologists, in 1980 in Massachusetts. Originally operating out of Ptashne's house in Boston, the company found more spacious quarters first in Boston and then Cambridge before expanding further. Gabriel Schmergel joined soon afterwards as CEO.〔(【引用サイトリンク】 title=Genetics Institute Inc )〕 Many leading scientists joined G.I. from academia and it proved to be a fertile source of patents for some time. ==Historical background== One of the two largest national clusters of biotechnology in the U.S. (the other being the San Francisco Bay area), the greater Boston area has been the birthplace of many innovative corporations and non-profit research centers. Beginning in the late 1970s and 1980s, this biotech trend saw three early large for-profit corporations: Biogen (now Biogen Idec), Genzyme, and Genetics Institute. MIT's Whitehead Institute was one of the seminal non-profit research centers in this field locally, among many others. Aside from MIT, Harvard, Boston University and several teaching hospitals including Massachusetts General Hospital and Brigham and Women's were important contributors to the local field's development. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Genetics Institute, Inc.」の詳細全文を読む スポンサード リンク
|